Advertisement
Home 2016

Archives

The number of hepatitis C-linked deaths in the United States reached a record high in 2014

CDC: Hepatitis C Leads Infectious Disease Mortality in U.S.

0
CDC notes that nearly 20,000 Americans died in 2014 from hepatitis C infection
The U.S. Food and Drug Administration said Thursday that it is banning the sale of electronic cigarettes to minors

New Rule Extends FDA Authority Over Tobacco, Nicotine Products

0
Agency banning the sale of electronic cigarettes to minors
Behavior modification therapy is preferable to medication for treating children 2 to 5 years old who have attention-deficit/hyperactivity disorder

CDC: Behavioral Therapy Recommended First for ADHD

0
Parents of young children with ADHD can help them improve through guidance
Physician leaders with good leadership qualities are more likely to have employees who are satisfied and do not show signs of burnout

Physician Leadership Training May Help Counteract Burnout

0
Leadership ratings strongly linked to employee burnout and satisfaction
European residents have access to the same health care services as U.S. residents but pay much less

Report: Why Health Care Costs Are Lower in Europe Than U.S.

0
Main reason for price difference is national system that negotiates with medical providers
Following a July 2015 Drug Safety Communication that warned about name confusion between Brintellix and Brilinta resulting in prescribing errors

FDA: Brintellix Changing Name to Avoid Confusion With Brilinta

0
Antidepressant changing name to Trintellix; meds with old brand name likely during transition period
The U.S. Preventive Services Task Force (USPSTF) concludes that the current evidence is insufficient to weigh the potential benefits and harms of screening for celiac disease in asymptomatic individuals. These findings form the basis of a draft recommendation statement published online May 3 by the USPSTF.

USPSTF: Evidence Lacking for Celiac Disease Screening

0
Evidence is inadequate for assessing harms, benefits of screening in asymptomatic individuals
Nuplazid (pimavanserin) has been approved by the U.S. Food and Drug Administration to treat hallucinations and delusions associated with Parkinson's disease.

FDA Approves Nuplazid for Parkinson’s Hallucinations

0
Half of patients with Parkinson's may experience hallucinations, delusions
The first generic version of Crestor (rosuvastatin calcium) tablets was approved Friday by the U.S. Food and Drug Administration.

Generic Crestor Approved by FDA

0
First generic version of Crestor (rosuvastatin calcium)
The first known Zika virus-linked death in Puerto Rico was announced Friday by officials of the U.S. territory.

First Zika-Related Death in Puerto Rico Reported

0
Result of severe thrombocytopenia caused by infection with the virus